Form 8-K - Current report:
SEC Accession No. 0001193125-21-249224
Filing Date
2021-08-17
Accepted
2021-08-17 16:41:43
Documents
3
Period of Report
2021-08-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d209324d8k.htm 8-K 18387
2 EX-99.1 d209324dex991.htm EX-99.1 7596
3 GRAPHIC g209324g15k25.jpg GRAPHIC 4980
  Complete submission text file 0001193125-21-249224.txt   34209
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40629 | Film No.: 211183297
SIC: 2836 Biological Products, (No Diagnostic Substances)